BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,050 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $235,384 | -17.2% | 6,237 | 0.0% | 0.01% | -15.4% |
Q2 2023 | $284,158 | +12.3% | 6,237 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $252,973 | -20.4% | 6,237 | 0.0% | 0.01% | -27.8% |
Q4 2022 | $317,900 | -5.4% | 6,237 | 0.0% | 0.02% | -5.3% |
Q3 2022 | $336,000 | -15.2% | 6,237 | +1.0% | 0.02% | -13.6% |
Q2 2022 | $396,000 | -17.3% | 6,173 | 0.0% | 0.02% | +4.8% |
Q1 2022 | $479,000 | -9.6% | 6,173 | 0.0% | 0.02% | +5.0% |
Q4 2021 | $530,000 | +6.9% | 6,173 | 0.0% | 0.02% | +5.3% |
Q3 2021 | $496,000 | -0.2% | 6,173 | 0.0% | 0.02% | 0.0% |
Q2 2021 | $497,000 | -4.6% | 6,173 | 0.0% | 0.02% | -13.6% |
Q1 2021 | $521,000 | -25.7% | 6,173 | -29.3% | 0.02% | -29.0% |
Q4 2020 | $701,000 | -0.1% | 8,733 | 0.0% | 0.03% | -13.9% |
Q3 2020 | $702,000 | -6.6% | 8,733 | 0.0% | 0.04% | -18.2% |
Q2 2020 | $752,000 | +53.5% | 8,733 | +44.8% | 0.04% | +10.0% |
Q1 2020 | $490,000 | -4.7% | 6,033 | -1.8% | 0.04% | +29.0% |
Q4 2019 | $514,000 | -5.3% | 6,143 | -1.0% | 0.03% | -13.9% |
Q3 2019 | $543,000 | +6.9% | 6,203 | 0.0% | 0.04% | +12.5% |
Q2 2019 | $508,000 | +17.9% | 6,203 | +17.1% | 0.03% | +10.3% |
Q1 2019 | $431,000 | +22.4% | 5,295 | -1.1% | 0.03% | 0.0% |
Q4 2018 | $352,000 | -14.8% | 5,355 | 0.0% | 0.03% | 0.0% |
Q3 2018 | $413,000 | +4.6% | 5,355 | 0.0% | 0.03% | -9.4% |
Q2 2018 | $395,000 | +14.8% | 5,355 | +1.1% | 0.03% | -30.4% |
Q1 2018 | $344,000 | – | 5,295 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |